File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Procedure-related myonecrosis after bare and drug-eluting stent implantation

TitleProcedure-related myonecrosis after bare and drug-eluting stent implantation
Authors
KeywordsAngioplasty
Coronary Artery Disease
Drug-Eluting Stents
Myocardial Infarction
Percutaneous Coronary
Transluminal
Issue Date2010
PublisherSage Publications Ltd.. The Journal's web site is located at http://www.sagepub.com/journalsProdDesc.nav?prodId=Journal201946
Citation
Asian Cardiovascular And Thoracic Annals, 2010, v. 18 n. 3, p. 272-278 How to Cite?
AbstractWe sought to compare the incidence of myonecrosis after elective implantation of bare metal stents with that of drug-eluting stents. The data of stable patients who were treated with stenting in a single native coronary artery were analyzed retrospectively. The stents used were bare metal in 119, sirolimus-eluting (Cypher Select Plus) in 119 patients, paclitaxel-eluting (Taxus Liberté) in 120, zotarolimus-eluting (Endeavor Sprint) in 122, and everolimus-eluting (Xience V) in 72. Endpoints included post-procedural myonecrosis (any elevation of creatine kinase-MB), myocardial infarction (creatine kinase-MB >3 times the upper limit of normal), and large myocardial infarction (creatine kinase-MB >5 times the upper limit of normal). The incidences of myonecrosis (16.7%-18.9%), myocardial infarction (3.3%-8.4%), and large myocardial infarction (1.7%-5.6%) were not significantly different among stent types. At the 30-day follow-up, there were 2 deaths in patients who had Taxus Liberté stents, one death each in those with Xience V and bare metal stents, and no cases of stroke or target vessel revascularization. In this study, bare metal stents and the 4 drug-eluting stents were associated with similar low incidences of myonecrosis, myocardial infarction, and large myocardial infarction. © 2010 SAGE Publications.
Persistent Identifierhttp://hdl.handle.net/10722/125059
ISSN
2015 SCImago Journal Rankings: 0.264
References

 

DC FieldValueLanguage
dc.contributor.authorLee, CHen_HK
dc.contributor.authorTse, HFen_HK
dc.contributor.authorTai, BCen_HK
dc.contributor.authorChen, Zen_HK
dc.contributor.authorChan, MYen_HK
dc.contributor.authorTan, HCen_HK
dc.date.accessioned2010-10-31T11:09:08Z-
dc.date.available2010-10-31T11:09:08Z-
dc.date.issued2010en_HK
dc.identifier.citationAsian Cardiovascular And Thoracic Annals, 2010, v. 18 n. 3, p. 272-278en_HK
dc.identifier.issn0218-4923en_HK
dc.identifier.urihttp://hdl.handle.net/10722/125059-
dc.description.abstractWe sought to compare the incidence of myonecrosis after elective implantation of bare metal stents with that of drug-eluting stents. The data of stable patients who were treated with stenting in a single native coronary artery were analyzed retrospectively. The stents used were bare metal in 119, sirolimus-eluting (Cypher Select Plus) in 119 patients, paclitaxel-eluting (Taxus Liberté) in 120, zotarolimus-eluting (Endeavor Sprint) in 122, and everolimus-eluting (Xience V) in 72. Endpoints included post-procedural myonecrosis (any elevation of creatine kinase-MB), myocardial infarction (creatine kinase-MB >3 times the upper limit of normal), and large myocardial infarction (creatine kinase-MB >5 times the upper limit of normal). The incidences of myonecrosis (16.7%-18.9%), myocardial infarction (3.3%-8.4%), and large myocardial infarction (1.7%-5.6%) were not significantly different among stent types. At the 30-day follow-up, there were 2 deaths in patients who had Taxus Liberté stents, one death each in those with Xience V and bare metal stents, and no cases of stroke or target vessel revascularization. In this study, bare metal stents and the 4 drug-eluting stents were associated with similar low incidences of myonecrosis, myocardial infarction, and large myocardial infarction. © 2010 SAGE Publications.en_HK
dc.languageengen_HK
dc.publisherSage Publications Ltd.. The Journal's web site is located at http://www.sagepub.com/journalsProdDesc.nav?prodId=Journal201946en_HK
dc.relation.ispartofAsian Cardiovascular and Thoracic Annalsen_HK
dc.subjectAngioplastyen_HK
dc.subjectCoronary Artery Diseaseen_HK
dc.subjectDrug-Eluting Stentsen_HK
dc.subjectMyocardial Infarctionen_HK
dc.subjectPercutaneous Coronaryen_HK
dc.subjectTransluminalen_HK
dc.titleProcedure-related myonecrosis after bare and drug-eluting stent implantationen_HK
dc.typeArticleen_HK
dc.identifier.emailTse, HF:hftse@hkucc.hku.hken_HK
dc.identifier.authorityTse, HF=rp00428en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1177/0218492310368732en_HK
dc.identifier.pmid20519297-
dc.identifier.scopuseid_2-s2.0-77956624709en_HK
dc.identifier.hkuros173635en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-77956624709&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume18en_HK
dc.identifier.issue3en_HK
dc.identifier.spage272en_HK
dc.identifier.epage278en_HK
dc.publisher.placeUnited Kingdomen_HK
dc.identifier.scopusauthoridLee, CH=27867783500en_HK
dc.identifier.scopusauthoridTse, HF=7006070805en_HK
dc.identifier.scopusauthoridTai, BC=7004532031en_HK
dc.identifier.scopusauthoridChen, Z=36476953200en_HK
dc.identifier.scopusauthoridChan, MY=23388249600en_HK
dc.identifier.scopusauthoridTan, HC=7403011676en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats